Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SKIN
SELLSkinHealth Systems Inc. · Consumer Defensive · United States · $95M · Avg Vol: $3M/d
COMPANY DESCRIPTION
The Beauty Health Company is a leading global developer and commercializer of aesthetic technologies and products, most notably the proprietary HydraFacial system. The company holds a strong market position through its innovative, non-invasive skin health treatments and a significant installed base of devices, generating recurring revenue from associated consumables. It primarily serves the professional aesthetics market with its advanced technologies.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 365.9M | 398.0M | 334.3M | 300.8M | -6.3% | 296.1M | 290.4M | 305.3M | 0.7% |
| EPS | 0.30 | -0.76 | -0.23 | -0.08 | — | -0.12 | — | — | — |
| Shares | 132.2M | 122.9M | 124.9M | 127.5M | -3.6% | 129.6M | — | — | — |
| Debt | 751.8M | 752.3M | 568.2M | 378.8M | -20.4% | 367.1M | — | — | — |
| Equity | 167.1M | 59.4M | 51.8M | 61.1M | -28.5% | — | — | — | — |
| Op CF | -106.6M | 21.8M | 16.1M | 37.5M | 31.3% | 28.9M | — | — | — |
| Inv CF | -18.9M | -31.5M | -6.8M | -5.2M | — | — | — | — | — |
| Fin CF | -205.2M | -37.4M | -158.3M | -174.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of SKIN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SKIN | SkinHealth Systems Inc.(you) | $95M | 25 | SELL |
| GROV | Grove Collaborative Holdings, Inc. | $55M | 13 | STRONG SELL |
| SLSN | Solesence, Inc. | $66M | 1 | STRONG SELL |
| 950140.KQ | Englewood Lab, Inc. | $103M | 65 | HOLD |
| ACU | Acme United Corporation | $206M | 62 | HOLD |
| HNST | The Honest Company, Inc. | $417M | 50 | HOLD |
| COTY | Coty Inc. | $2.3B | 25 | SELL |
| NUS | Nu Skin Enterprises, Inc. | $247M | 79 | BUY |
| MAGN | Magnera Corporation | $488M | 73 | BUY |
| HELE | Helen of Troy Limited | $663M | 75 | BUY |
Peer medians: ROE 12.3% · P/E 21.4x · Gross margin 35.0%